HIV drug and supply stock-outs in Latin America

The Lancet Infectious Diseases

Volumn 11, Issue 11, 2011, Pages 810-811

  Sued, Omar ^a   Schreiber, Casey ^a   Girón, Nora ^a   Ghidinelli, Massimo ^a  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; FOSAMPRENAVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; CLINICAL PROTOCOL; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY; LETTER; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; RISK FACTOR; SOUTH AND CENTRAL AMERICA; TREATMENT FAILURE; TREATMENT RESPONSE; VERTICAL TRANSMISSION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; LATIN AMERICA; PAN AMERICAN HEALTH ORGANIZATION;

EID: 82455188246     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70301-2     Document Type: Letter

References (5)

1. Pasquet A, Messou E, Gabillard D, et al. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One 2010, 5:e13414.
2. Harries AD, Schouten EJ, Makombe SD, et al. Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bull World Health Organ 2007, 85:152-155.
3. Schouten EJ, Jahn A, Ben-Smith A, et al. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc 2011, 14(suppl 1):S4.
4. Arán-Matero D, Amico P, Arán-Fernandez C, Gobet B, Izazola-Licea JA, Avila-Figueroa C Levels of spending and resource allocation to HIV programs and services in Latin America and the Caribbean. PLoS One 2011, 6:e22373.
5. Hirnschall G, Schwartländer B Treatment 2.0: catalysing the next phase of scale-up. Lancet 2011, 378:209-211.